Abstract
Background
We recently showed that an 8-week preoperative protein-enriched diet (PED) is associated with significant reductions in body weight and fat mass (FM) without significant loss of fat-free mass (FFM) in morbidly obese patients scheduled for laparoscopic sleeve gastrectomy (LSG).
Objectives
The objective of this study is to evaluate the impact of PED vs a normal protein diet (NPD) on total weight loss (TWL), FM, FFM, and resting metabolic rate (RMR) in patients after LSG.
Methods
Before LSG and at 3, 6, and 12 months after, we prospectively measured and compared total body weight (TBW), FM, FFM, and RMR in 60 male patients who received either a NPD (n = 30) with protein intake 1.0 g/kg of ideal body weight, or a PED (n = 30) with protein intake 2.0 g/kg of ideal body weight. Compliance in following the prescribed diet was determined with food frequency questionnaires in all patients. The impact of NPD and PED on renal function was also evaluated.
Results
Despite non-significant variation in total body weight (TBW), FM decreased more significantly (p < 0.01) with the PED compared to the NPD. In addition, the PED group showed a significantly (p < 0.01) lower decrease in FFM and RMR when compared with the NPD group. Both groups showed high compliance in following the prescribed diets, without negative impact on renal function.
Conclusion
PED is more effective than NPD in determining FM loss and is associated with a lower decrease in FFM and RMR, without interfering with renal function in male patients after LSG.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
An important goal during weight loss is to maximize fat mass (FM) loss while preserving metabolically active fat-free mass (FFM) [1]. Maintaining adequate FFM is an important consideration when making dietary intake recommendations for weight loss because muscles play a central role in whole-body protein metabolism [2]. Additionally, a significant decrease in FFM may negatively affect the resting metabolic rate (RMR) [3], slow the rate of weight loss, and predispose to weight regain [4]. In 2010, Mettler et al. [5] demonstrated that consuming dietary protein at 2.3 g kg−1 day−1 was superior to 1.0 g kg−1 day−1 (recommended dietary allowance; RDA) for the maintenance of FFM in young athletes. Recently, Pasiakos et al. [6] demonstrated with volunteer military personnel from the U.S. army that consuming 1.6 g kg−1 day−1 (twice the RDA) is enough to protect FFM during short-term weight loss.
Laparoscopic sleeve gastrectomy (LSG) is one of the most performed bariatric surgery procedures for long-term treatment of morbid obesity [7–9] mainly because of its simple surgical technique that does not include any digestive anastomosis and leaves the continuity of the digestive tract intact. Furthermore, LSG results in weight loss and obesity-related comorbidities that are comparable to what is achievable with more complex procedure such as the Roux-en-Y gastric bypass [10–12]. Most nutritional guidelines suggest that after LSG, protein intake should be around 1 g/kg of ideal body weight per day [13, 14]. However, some studies reveal that using this amount of protein markedly changes FFM after LSG [15–17].
We have recently shown that in obese patients scheduled for LSG, an 8-week preoperative protein-enriched diet (PED) is associated with significant reductions in body weight and fat mass (FM) without a significant loss of fat-free mass (FFM) [18]. Therefore, the present study aims to evaluate the clinical impact of PED vs normal protein diet (NPD) on total weight loss (TWL), FM, FFM, and RMR in morbidly obese patients that underwent LSG.
Materials and Methods
Patient Selection
We prospectively assessed 60 obese men that consecutively underwent LSG at our university hospital between 2011 and 2014. All patients fulfilled the criteria established by the International Federation for Surgery of Obesity for surgical treatment [19]. Only men were included to reduce hormonal interference (i.e., changes in hydration status related to menstrual cycle or menopausal conditions). The inclusion criteria were: body mass index (BMI) ≥40 kg/m2, or ≥35 kg/m2 with comorbidities related to obesity and age between 18 to 65 years. Patients with previous gastrointestinal surgery, gastro-esophageal reflux disease, digestive and/or inflammatory bowel diseases, mental illness, and inability to comply with the PED or NPD for religious reasons or the presence of chewing or swallowing disorders, were excluded from the study groups. Patients after LSG were randomized into two groups: the NPD group (n = 30) that followed a NPD (protein intake 1.0 g/kg ideal body weight diet) [13, 14] and the PED group (n = 30) that followed a PED (protein intake 2.0 g/kg ideal body weight diet) [18].
Preoperative Characteristics of the Study Population
Preoperative age, height, and BMI were 41 ± 6.2 years, 1.76 ± 2.4 cm, and 40.7 ± 5.3 kg/m2 in the NPD group, and 43 ± 5.5 years, 1.78 ± 3.4 cm, and 42.1 ± 6.2 kg/m2 for the PED group, respectively. Preoperative total body weight (TBW), FM (% and kg), FFM (% and kg), and RMR are reported in Fig. 1.
NPD and PED Characteristics
Consistent with current guidelines [14, 15], after discharge, patients assumed a liquid diet, a puree-based diet after 15 days, and a soft solid food diet after 4 weeks. To ensure patients of both groups consumed a similar diet, we developed three NPD and PED postoperative meal plans (each consisting of 1200 kcal/day) using foods and ingredients reported in Fig. 2: plan 1 (months 1 to 4), plan 2 (months 5 to 8), and plan 3 (months 9 to 12) using Nutrigeo 8 software (Progeo, Ascoli Piceno, Italy). NPD and PED composition provided a protein intake of 1.0- and 2.0-g/kg ideal body weight, respectively (Fig. 2). In both NPD and PED groups, ideal body weight was calculated using a BMI of 22.5 kg/m2 and, based on preoperative characteristics, was fixed on 70 kg for the NPD group and 71.5 kg for the PED group. In both groups, the diet’s fat percentage was fixed at 15 %; the NPD was consequently more rich in carbohydrates (61.7 %) than the PED (37.3 %). Macronutrient composition of both the NPD and PED are reported in Fig. 2. In addition, after discharge, all patients received the same commercially available mineral and vitamin supplement (WLS Optimum, Fit for me, Orte, Italy) specially formulated for obese patients and/or those who have undergone surgery for obesity [20].
Anthropometric, Body Composition and RMR Measurements
Measurements were performed before LSG, and at three, six, and 12 months after. Body weight (in kilogram) and height (in centimeter) were determined under standard conditions. Height was measured using a Seca 206 mechanical measuring tape (Intermed, Milano, Italy); body weights were assesed by Seca 869 flat digital scale (capacity 250 kg, Intermed).
Patients’ body composition were measured by bioelectrical impedance assay ( BIA) using the Jawon IOI 353 Segmental Body Composition Monitor (Cosmed, Rome, Italy). The instrument used is the last generation in body composition analysis, use the latest multi-frequency technology and it is in compliance with the requirements of the Directive 90/384/EEC for weighing with non-automatic devices in the medical sector and the Directive 93/42/EEC for medical devices.
To perform an appropriate analysis, as we previously reported [18], all patients were required to comply with these conditions prior to the BIA: no food ingestion for at least 4 h, minimal intake of 2 L of water the day before, no physical activity for at least 8 h, no coffee or alcoholic beverage consumption during at least 12 h, and no diuretic use for at least 24 h. Patients were also asked to empty their bladder immediately prior to the BIA test. Patient’s RMR were measured by indirect calorimetry using Fitmat PRO monitor (Cosmed). Examinations were performed from 8:00 to 10:00 am in the same room under thermos neutral conditions, in order to reduce diurnal variation between subjects [21–24]. Measurements were performed at a duration of 15 min following a prior 5- to 10-min test.
Dietary Compliance Assessment Methods
Nutritional assessment and dietary counseling were scheduled at 3, 6, and 12 months after LSG. Dietary assessments were primarily performed using questionnaires (3-day estimated food records and 72-h recalls) [25]. Nutrient intakes were calculated from the 72-h recalls and 3-day dietary records (Sunday to Tuesday; breakfast to bedtime) using Nutrigeo 8 software.
Measurement of Blood Parameters
Biochemical and hematologic tests were conducted preoperatively and at 12 months after LSG in both groups (Table 1).
Statistical Analysis
The effects of post-LSG NPD and PED program were directly compared by using the paired sample t test for continuous variables (Graph Pad Software, La Jolla, CA, USA). The pattern of TBW, FM, FFM, and RMR changes during the period study was expressed as a percentage and plotted over time. Simple bivariate analysis was used to assess the correlation between FFM loss and protein intake. A p value <0.05 was considered statistically significant.
Results
Impact of NPD and PED on TBW, FM, FFM, and RMR
Before surgery, NPD and PED groups had a normal protein preoperative diet and were comparable in terms of TBW, FM, FFM, whereas PED group RMR was significantly (p < 0.01) higher than the NPD group (Fig. 1 a–f). Three patients dropped out of the NPD group and two from the PED group. As expected, we observed that TBW and FM (in percent and in kilogram) markedly changed after surgery in both groups (Fig. 1a–c). However, we did not observe any significant difference between the two groups in terms of TBW lost. Patients who followed the PED lost significantly more FM (in percent and in kilogram) at 3 (p < 0.01), 6 (p < 0.01), and 12 months after surgery (p < 0.01) than patient who followed the NPD. On the contrary, patients that followed the PED lost less FFM (in percent) at 3 (p < 0.01), 6 (p < 0.01), and 12 months after surgery (p < 0.01), than patients who followed the NPD (Fig. 1d). PED patients lost significantly less FFM (in kilogram) at 6 (p < 0.05) and 12 months (p < 0.01) after surgery (Fig. 1e).
The FFM loss was highly correlated with the protein intake (r = 0.61; p < 0.001). Finally, patients that followed the PED showed a significantly higher RMR at 3 (p < 0.01), 6 (p < 0.01), and 12 months (p < 0.01) after LSG than patients who followed the NPD (Fig. 1f).
Three-Day Estimated Food Records Vs 72-H Recalls
No significant differences in the estimated nutrient intake were observed between the 72-h recalls and the 3-day estimated food records in both NPD and PED groups. Values for energy intake (expressed in kilocalorie per day) and all macronutrients reported during the 72-h recalls were strictly similar to those of the 3-day estimated records, indicating a high patient’s compliance of following the prescribed diets in both group studies (Tables 2 and 3).
Impact of NPD and PED on patient’s Clinical Parameters
Both NPD and PED patients showed a marked improvement in several clinical parameters, including liver enzyme levels, glycemic, and lipid profiles, while no change on renal function was observed (Table 1).
Discussion
This study indicates that PED is more effective than NPD in determining FM loss and is associated with a lower decrease in FFM and RMR, without interfering with renal function in male morbidly obese patients undergoing LSG. In accordance with Belfiore et al. [17], we found that NPD is associated with a remarkable loss of FFM at 3 and 6 months after surgery. Indeed, Belfiore et al. [17] reported the proportion of body mass loss attributable to FFM to be 12 and 15.7 % at 3 and 6 months after LSG, respectively. In the present study, the proportion of body mass loss attributable to FFM, at 3, 6, and 12 months after LSG were 8.5, 13.8, and 19.8 %, respectively. Although Belfiore at al. [17] suggested that FFM loss took place because of poor patient compliance in following the postoperative diet, we found that FFM loss was independent of patient compliance. In fact, despite the NPD group being strictly compliant, FFM loss was significantly higher than in the PED group, suggesting that the significant reduction in FFM observed is mainly attributable to protein intake deficiency (Tables 2 and 3). Furthermore, our findings are in accordance with those recently reported by Schollenberger et al. [26] that showed that postoperative protein supplement might facilitate body fat loss, and protect against FFM wasting, without negative impact on renal function. In addition, and more importantly, to the best of our knowledge, this is the first study that demonstrates how the preservation of FFM during the LSG postoperative weight loss period has a positive impact on RMR. The present study suggests that a post-LSG PED induces a larger reduction of FM without a significant drop of FFM and RMR when compared to a NPD, highlighting the importance of a high protein diet to maintain FFM.
Considering that bariatric surgery deeply effects FFM, as suggested by Thibault et al. [27], one of the key nutritional issues to measure body before and after surgery to quantify these changes, and that protein and general diet composition should be adjusted to manage the risk of FFM depletion after surgery. In the present study, body composition was measured by BIA. We were aware that BIA in severely obese patients has been criticized because these patients may have altered electrical properties in their body tissues, which could cause an overestimation of FFM and an underestimation of FM [28, 29]. However, several studies conducted in obese patients validate the use of BIA for the measure of body composition, indicating that it is reliable and reproducible [18, 30–32]. However, we also monitored the changes in total body water (TBWt) and body cellular mass (BCM) in both groups by BIA (Fig. 2). In accordance with previous reports [17], we observed 3 months after surgery, a significant (p < 0.05) decrease in BCM (Fig. 2g) in the NPD group with no significant changes in TBWt (Fig. 2h). On the contrary, we show for the first time that a postoperative enriched-protein diet is also able to positively impact BCM. In particular, in the PED group we observed a significant (p < 0.05) increase in BCM (Fig. 2g), with no changes in TBWt at 3, 6 and 12 months after surgery (Fig. 2h). Considering that BCM is an important factor in determining RMR [33], and has also been reported as a valuable indicator of nutritional status [34], our data suggests that a postoperative protein-enriched diet is able to better preserve RMR by positively impacting the FFM and BCM.
Finally, PED appears safe, considering that not only is it associated to an important improvement in patient’s clinical status (Table 1) but also seems not to affect renal function. The present study has certain limitations. First, despite after discharge the physical activity was encouraged, we do not directly measure it. Secondarily, FM and FFM were only measured by BIA and were not supplemented with additional comparative measures. We are aware that measurements of body composition by others techniques, such as computed tomography (CT), can be more accurate. However, it would have been impossible to do a CT scan in most of the studied patients because of their weight. Furthermore, CT scan is not cost-effective and radiation exposure would not be acceptable for ethical issues. Furthermore, BIA has several advantages over other methods, such as high safety, noninvasiveness, low cost, ease of use, high reproducibility, and adaptability to medical routine. Second, this was a comparative cohort study involving a gender-biased sample. The reason is because, as reported in a recent review by Mialich and coworkers [35], standardization of measurement conditions is essential for obtaining accurate and reproducible BIA. Various individual factors have been shown to influence BIA. Overall, the within-subject total body impedance variability is higher in women, which appears to be due to changes in hydration status related to menstrual cycle [35].
Conclusion
Based on the present findings, we are able to support the hypothesis that in patients undergoing LSG, PED is more effective than NPD in determining FM loss and is associated with a significantly lower decrease in FFM and RMR, without interfering with renal function. All subjects showed a high compliance in following the prescribed diet and no unfavorable anthropometric, biochemical, or clinical outcomes were found.
These results should be confirmed in a larger randomized trial.
References
Johannsen DL, Knuth ND, Huizenga R, et al. Metabolic slowing with massive weight loss despite preservation of fat-free mass. J Clin Endocrinol Metab. 2012;97(7):2489–96.
Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006;84(3):475–82.
Ebbeling CB, Swain JF, Feldman HA, et al. Effect of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012;307(24):2627–34.
Ravussin E, Lillioja S, Knowler WC, et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med. 1988;318(8):467–72.
Mettler S, Mitchell N, Tipton KD. Increased protein intake reduces lean body mass loss during weight loss in athletes. Med Sci Sports Exerc. 2010;42(2):326–37.
Pasiakos SM, Cao JJ, Margolis LM, et al. Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. FASEB J. 2013;27(9):3837–47.
Sherman V, Brethaer SA, Chand B, et al. Laparoscopic sleeve gastrectomy. In: Schauer PR, Schirmer BD, Brethaer SA, editors. Minimally invasive bariatric surgery. New York: Springer Inc; 2007. p. 173–9.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Clin Nutr. 2015 Oct;25(10):1822–32.
Gentileschi P. Laparoscopic sleeve gastrectomy as a primary operation for morbid obesity: experience with 200 patients. Gastroenterol Res Pract. 2012;2012:801325.
Van Rutte PW, Smulders JF, de Zoete JP, et al. Outcome of sleeve gastrectomy as a primary bariatric procedure. Br J Surg. 2014;101(6):661–8.
Abu-Jaish W, Rosenthal RJ. Sleeve gastrectomy: a new surgical approach for morbid obesity. Expert Rev Gastroenterol Hepatol. 2010;4(1):101–19.
Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.
Committee AHSSAHN, Aills L, Blankenship J, et al. Allied health nutritional guidelines for the surgical weight loss patient. Surg Obes Relat Dis. 2008;4(5 Suppl):S73–108.
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by America Association of Clinical Endocrinologists, The Obesity Surgery, and The American Society for Metabolic & Bariatric Surgery. Obesity. 2013;21(Suppl 1):S1–27.
Chaston TB, Dixon JB, O’Brien PE. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes. 2007;31(5):743–50.
Wells J, Miller M, Perry B, et al. Preservation of fat-free mass after bariatric surgery: a comparison of malabsorptive and restrictive procedures. Am Surg. 2015;81(8):812–5.
Belfiore A, Cataldi M, Minichini L, et al. Short-term changes in body composition and response to micronutrient supplementation after laparoscopic sleeve gastrectomy. Obes Surg. 2015;25(12):2344–51.
Schiavo L, Scalera G, Sergio R, et al. Clinical impact of Mediterranean enriched-protein diet on liver size, visceral fat, fat mass, and fat-free mass in patients undergoing sleeve gastrectomy. Surg Obes Relat Dis. 2015;11(5):1164–70.
Fried M, Yumuk V, Oppert JM, et al. International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC); European Association for the Study of Obesity (EASO); European Association for the Study of Obesity Obesity Management Task Force (EASO OMTF). Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014 Jan;24(1):42–55.
Schiavo L, Scalera G, Pilone V, et al. Micronutrient deficiencies in patients candidate for bariatric surgery: a prospective, preoperative trial of screening, diagnosis, and treatment. Int J Vitam Nutr Res. 2016 May 10:1–8. doi:10.1024/0300-9831/a000282.
Haugen HA, Chan LN, Li F. Indirect calorimetry: a practical guide for clinicians. Nutr Clin Pract. 2007;22(4):377–88.
Nieman DC, Austin MD, Benezra L, et al. Validation of Cosmed’s FitMate in measuring oxygen consumption and estimating resting metabolic rate. Res Sports Med. 2006;14(2):89–96.
Haugen HA, Melanson EL, Tran ZV, et al. Variability of measured resting metabolic rate. Am J Clin Nutr. 2003;78(6):1141–5.
Compher C, Frankenfield D, Keim N, et al. Evidence analysis working group. Best practice methods to apply to measurement of resting metabolic rate in adults: a systematic review. J Am Diet Assoc. 2006;106(6):881–903.
Schröder H, Covas MI, Marrugat J, et al. Use of a three-day estimated food record, a 72-h recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin Nutr. 2001 Oct;20(5):429–37.
Schollenberger AE, Karschin J, Meile T, et al. Impact of protein supplementation after bariatric surgery: a randomized controlled double-blind pilot study. Nutrition. 2016;32(2):186–92.
Thibault R, Huber O, Azagury DE, et al. Twelve key nutritional issues in bariatric surgery. Clin Nutr 2016;35(1):12–7.
Deurenberg P. Limitation of the bioelectrical impedance method for the assessment of body fat in severe obesity. Am J Clin Nutr. 1996;64(3 Suppl):449S–52S.
Leal AA, Faintuch J, Morais AA, et al. Bioimpedance analysis: should be used in morbid obesity? Am J Hum Biol. 2011;23(3):420–2.
Das SK, Roberts SB, Kehayias JJ, et al. Body composition assessment in extreme obesity and after massive weight loss induced by gastric bypass surgery. Am J Physiol Endocrinol Metab. 2003;284(6):1080–8.
Faria SL, Faria OP, Cardeal MD, et al. Validation study of multi-frequency bioelectrical impedance with dual-energy X-ray absorptiometry among obese patients. Obes Surg. 2014;24(9):1476–80.
Ballesteros-Pomar MD, Calleja-Fernández A, Diez-Rodríguez R, et al. Comparison of different body composition measurements in severely obese patients in the clinical setting. Nutr Hosp. 2012;27(5):1626–30.
Roubenoff R. The pathophysiology of wasting in the elderly. J Nutr. 1999;129(1S Suppl):256S–9S.
Wang Z, St-Onge MP, Lecumberri B, et al. Body cell mass: model development and validation at the cellular level of body composition. Am J Physiol Endocrinol Metab. 2004;286(1):E123–8.
Mialich MS, Sicchieri JM, Jordao AA. Analysis of body composition: a critical review of the use of bioelectrical impedance analysis. Int J Clin Nutr. 2014;2(1):1–10.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no conflicts of interest.
Informed Consent
Written informed consent was obtained for each individual participant included in the study.
Ethical Approval
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments. Research Registry Identifier Number 1566.
Rights and permissions
About this article
Cite this article
Schiavo, L., Scalera, G., Pilone, V. et al. A Comparative Study Examining the Impact of a Protein-Enriched Vs Normal Protein Postoperative Diet on Body Composition and Resting Metabolic Rate in Obese Patients after Sleeve Gastrectomy. OBES SURG 27, 881–888 (2017). https://doi.org/10.1007/s11695-016-2382-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-016-2382-y